SFX by Ex Libris Inc.

Title:	iRhom2 regulation of TACE controls TNF-mediated protection against Listeria and responses to LPS
Source:	Science [0036-8075] McIlwain, D R yr:2012

Basic

Sorry, no full text available...

Please use the document delivery service (see below)

Holding information

Holdings in library search engine ALBERT

Document delivery

Request document via Library/Bibliothek

Users interested in this article also expressed an interest in the following:
description	1.	Harrison, R. "Rapamycin fed late in life extends lifespan in genetically heterogeneous mice." Nature 460.7253 (2009): 392-5.
description	2.	Girijavallabhan, Vinay M. "Novel TNF-α converting enzyme (TACE) inhibitors as potential treatment for inflammatory diseases." Bioorganic and medicinal chemistry letters 20.24 (2010): 7283-7287.
description	3.	Jger, S. "Vif hijacks CBF-β to degrade APOBEC3G and promote HIV-1 infection." Nature 481.7381 (2011): 371-375.
description	4.	Hoek, T.L. Vanden B. "Reactive oxygen species released from mitochondria during brief hypoxia induce preconditioning in cardiomyocytes." The Journal of biological chemistry 273.41 (1998): 18092-18098.
description	5.	Minucci, S. "Histone deacetylase inhibitors and the promise of epigenetic (and more) treatments for cancer." Nature reviews. Cancer 6.1 (2006): 38-51.
description	6.	Colman, Ricki J. "Caloric restriction delays disease onset and mortality in rhesus monkeys." Science 325.5937 (2009): 201-206.
description	7.	Matt Kaeberlein; Brian K. Kennedy;, Matt K. "Ageing: A midlife longevity drug?" Nature 460.7253 (2009): 331-2.
description	8.	Marks, P. "Histone deacetylases and cancer: causes and therapies." Nature reviews. Cancer 1.3 (2002): 194-202.
description	9.	Johnstone, Ricky W W. "Histone-deacetylase inhibitors: Novel drugs for the treatment of cancer." Nature reviews. Drug discovery 1.4 (2002): 287-299.
description	10.	Lahouassa H, H. "SAMHD1 restricts the replication of human immunodeficiency virus type 1 by depleting the intracellular pool of deoxynucleoside triphosphates." Nature Immunology 13.3 (2012): 223-228.
description	11.	De-Maio, Federico A. "APOBEC3 mediated editing in HIV-1 from pediatric patients and its association with APOBEC3G/CUL5 polymorphisms and Vif variability." AIDS research and human retroviruses 28.6 (2011): 619-627.
description	12.	Moseley, J. "A spatial gradient coordinates cell size and mitotic entry in fission yeast." Nature 459.7248 (2009): 857-60.
description	13.	Carew, J. "Histone deacetylase inhibitors: Mechanisms of cell death and promise in combination cancer therapy." Cancer Letters 269.1 (2008): 7-17.
description	14.	Kapahi, P. "Regulation of Lifespan in Drosophila by Modulation of Genes in the TOR Signaling Pathway." Current biology 14.10 (2004): 885-890.
description	15.	Paris, M. "Histone deacetylase inhibitors: From bench to clinic." Journal of medicinal chemistry 51.6 (2008): 1505-1529.
description	16.	De Ruijter, A. "Histone deacetylases (HDACs): characterization of the classical HDAC family." The Biochemical journal 370.Pt3 (2003): 737-749.
description	17.	Lian, J. "The mammalian target of rapamycin pathway and its role in molecular nutrition regulation." Molecular nutrition & food research 52.4 (2008): 393-9.
description	18.	Xu, J. "Efficient synthesis of N-protected 1-substituted homotaurines from a xanthate and olefins." Tetrahedron 69.3 (2013): 1050-1056.
description	19.	Brower, Roy G. "Treatment of ARDS *.(acute respiratory distress syndrome)." Chest 120.4 (2001): 1347-.
description	20.	Ori, M. "Stereospecific construction of contiguous quaternary and tertiary stereocenters by rearrangement from indoline-2-methanol to 2,2,3-trisubstituted tetrahydroquinoline: Application to an efficient total synthesis of natural virantmycin." Angewandte Chemie (International ed. in English) 42.22 (2003): 2540-2543.